Propanc Health Group Corp Share Price Other OTC
Equities
US74345C1027
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | - | Sales 2023 | - | Capitalization | 559K 44.71M |
---|---|---|---|---|---|
Net income 2022 | -2M -160M | Net income 2023 | -2M -160M | EV / Sales 2022 | - |
Net Debt 2022 | 1.09M 87.6M | Net Debt 2023 | 536K 42.9M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.07
x | P/E ratio 2023 |
-0.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.69% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 14/10/07 | |
Julian Kenyon
FOU | Founder | 77 | 14/10/07 |
Klaus Kutz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 14/10/07 | |
Julian Kenyon
FOU | Founder | 77 | 14/10/07 |
Josef Zelinger
BRD | Director/Board Member | 74 | 22/12/20 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |